---
figid: PMC4805599__fnagi-08-00058-g0001
figtitle: GPCRs mediated signaling pathways
organisms:
- Mus musculus
- Rattus norvegicus
- Meleagris gallopavo
- Arripis georgianus
- Homo sapiens
- Bos taurus
- Human immunodeficiency virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC4805599
filename: fnagi-08-00058-g0001.jpg
figlink: /pmc/articles/PMC4805599/figure/F1/
number: F1
caption: 'Model of GPCRs mediated signaling pathways. In classical model, heterotrimeric
  G proteins (α, β, γ subunits) mediate signal transduction via the receptor. Signal
  transduction initiated when ligands bind to GPCRs. The resulting conformation change
  promotes the exchange of GDP for GTP on the Galpha subunit of G proteins. Gs activates
  AC leading to the production of cAMP in cells, then cAMP binds to the regulatory
  subunit of PKA, regulating the phosphorylation of the GPCR and leading the process
  of desensitization of GPCR. PKA can regulate the level of CREB (Zeitlin et al.,
  ) and mediates MAPK ERK pathway (New and Wong, ). Gq/11 controls the activity of
  PLC, which hydrolyzes PIP2 to generate IP3 and DAG. IP3 and DAG in turn lead to
  an increase in the intracellular concentrations of free Ca2+, regulation of NFκB
  (Arendash et al., ) and the activation of a number of protein kinases and pathways,
  including PKC/MAPK/ERK (Ritter and Hall, ). GPCR activate PI3K/Akt cascades through
  Gβγ (New and Wong, ). Gi inhibits AC, and G12/13 is suggested to activate GSK3 in
  neuronal cells (Sayas et al., ,). GSK3 is involved in tau phosphorylation with regard
  to AD pathology (Ly et al., ). And Akt and PKC can inhibit GSK3 activity (New and
  Wong, ; Langmead et al., ). Abbreviations: GPCR(s), G protein-coupled receptor(s);
  GDP, guanosine diphosphate; GTP, guanosine triphosphate; AC, adenyl cyclase; cAMP,
  cyclic adenosine monophosphate; PKA, protein kinase A; CREB, cAMP response element-binding
  protein; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated
  kinase; PLC, phospholipase C; PIP2, phosphatidylinositol 4, 5-bisphosphate; IP3,
  inositol triphosphate; DAG, diacylglycerol; NFκB, nuclear factor kappa-light-chain-enhancer
  of activated B cells; PKC, protein kinase C; PI3K, phosphotidylinositol 3-kinase;
  Akt, protein kinase B; GSK3, glycogen synthase kinase-3; AD, Alzheimer’s Disease.'
papertitle: 'G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on
  BACE1 Related GPCRs.'
reftext: Juan Zhao, et al. Front Aging Neurosci. 2016;8:58.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9560638
figid_alias: PMC4805599__F1
figtype: Figure
redirect_from: /figures/PMC4805599__F1
ndex: e329eb8f-dedf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4805599__fnagi-08-00058-g0001.html
  '@type': Dataset
  description: 'Model of GPCRs mediated signaling pathways. In classical model, heterotrimeric
    G proteins (α, β, γ subunits) mediate signal transduction via the receptor. Signal
    transduction initiated when ligands bind to GPCRs. The resulting conformation
    change promotes the exchange of GDP for GTP on the Galpha subunit of G proteins.
    Gs activates AC leading to the production of cAMP in cells, then cAMP binds to
    the regulatory subunit of PKA, regulating the phosphorylation of the GPCR and
    leading the process of desensitization of GPCR. PKA can regulate the level of
    CREB (Zeitlin et al., ) and mediates MAPK ERK pathway (New and Wong, ). Gq/11
    controls the activity of PLC, which hydrolyzes PIP2 to generate IP3 and DAG. IP3
    and DAG in turn lead to an increase in the intracellular concentrations of free
    Ca2+, regulation of NFκB (Arendash et al., ) and the activation of a number of
    protein kinases and pathways, including PKC/MAPK/ERK (Ritter and Hall, ). GPCR
    activate PI3K/Akt cascades through Gβγ (New and Wong, ). Gi inhibits AC, and G12/13
    is suggested to activate GSK3 in neuronal cells (Sayas et al., ,). GSK3 is involved
    in tau phosphorylation with regard to AD pathology (Ly et al., ). And Akt and
    PKC can inhibit GSK3 activity (New and Wong, ; Langmead et al., ). Abbreviations:
    GPCR(s), G protein-coupled receptor(s); GDP, guanosine diphosphate; GTP, guanosine
    triphosphate; AC, adenyl cyclase; cAMP, cyclic adenosine monophosphate; PKA, protein
    kinase A; CREB, cAMP response element-binding protein; MAPK, mitogen-activated
    protein kinase; ERK, extracellular signal-regulated kinase; PLC, phospholipase
    C; PIP2, phosphatidylinositol 4, 5-bisphosphate; IP3, inositol triphosphate; DAG,
    diacylglycerol; NFκB, nuclear factor kappa-light-chain-enhancer of activated B
    cells; PKC, protein kinase C; PI3K, phosphotidylinositol 3-kinase; Akt, protein
    kinase B; GSK3, glycogen synthase kinase-3; AD, Alzheimer’s Disease.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gy
  - gp
  - Gan
  - Hspg2
  - Gsk3b
  - Pik3r1
  - ac
  - Akt1
  - Mapt
  - Csnk1e
  - Nfkb1
  - Creb1
  - Ephb2
  - Mapk1
  - Gpbar1
  - GAN
  - GNA12
  - GNA13
  - ATF6B
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - GSK3A
  - GSK3B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - AKT1
  - AKT2
  - AKT3
  - MAPT
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - Pik3cg
  - Prkcg
  - Rela
  - Ephb1
  - Tas2r134
  - Rxfp2
  - gy
  - norpA
  - sl
  - Plc21C
  - sgg
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - tau
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Dif
  - dl
  - Rel
  - CrebB
  - CrebA
  - MKP-4
  - p38b
  - rl
  - Erk7
  - Oamb
  - Cancer
---
